Document is current
Any future updates will be listed below
-
Authors
Abdelazeem, Khalid N. M.
Nguyen, Diemmy https://orcid.org/0000-0002-2035-643X
Corbo, Sophia
Darragh, Laurel B. https://orcid.org/0000-0002-6445-7988
Matsumoto, Mike W. https://orcid.org/0009-0001-0618-7799
Van Court, Benjamin https://orcid.org/0000-0001-5860-4489
Neupert, Brooke
Yu, Justin
Olimpo, Nicholas A. https://orcid.org/0000-0001-6556-2168
Osborne, Douglas Grant
Gadwa, Jacob
Ross, Richard B.
Nguyen, Alexander https://orcid.org/0009-0004-1108-2176
Bhatia, Shilpa https://orcid.org/0009-0005-7222-9845
Kapoor, Mohit https://orcid.org/0000-0001-7994-110X
Friedman, Rachel S. https://orcid.org/0000-0001-7549-6387
Jacobelli, Jordan https://orcid.org/0000-0001-6612-6704
Saviola, Anthony J. https://orcid.org/0000-0001-6890-512X
Knitz, Michael W. https://orcid.org/0000-0002-5786-9837
Pasquale, Elena B. https://orcid.org/0000-0002-5076-4848
Karam, Sana D.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01DE028529 (SDK))
U.S. Department of Health & Human Services | National Institutes of Health (R01CA28465 (SDK))
U.S. Department of Health & Human Services | National Institutes of Health (P50CA261605-01 (SDK))
U.S. Department of Health & Human Services | National Institutes of Health (P30 DK063720)
U.S. Department of Health & Human Services | National Institutes of Health (P30 DK063720)
V Foundation for Cancer Research (V Foundation (SDK)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F31 DE029997)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F31 DE033887-01)
- License Information
-
More Information
Article History
Received: 6 July 2024
Revised: 19 October 2024
Accepted: 23 October 2024
First Online: 3 November 2024
Competing interests
: Dr. Karam receives clinical funding from Genentech that does not relate to this work. She receives clinical trial funding from AstraZeneca which is not related to this manuscript. She also receives preclinical research funding from Roche and Amgen, neither one of which is related to this manuscript. The remaining authors declare no competing interests.
: All mice were handled and euthanized consistent with the ethics guidelines and conditions set and overseen by the University of Colorado, Anschutz Medical Campus Animal Care and Use Committee. The study has been approved by the Institutional Animal Care and Use Committee (Protocol number: 250). This study did not use any human subjects or identifiable images from human research patients.
